Navigation Links
Onyx Pharmaceuticals to Present at Upcoming Investor Conferences
Date:2/21/2012

SOUTH SAN FRANCISCO, Calif., Feb. 21, 2012 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at four investor conferences in February and March.

2012 Citi Global Healthcare Conference
Onyx will present at the 2012 Citi Global Healthcare Conference on Monday, February 27, 2012 at 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time). 

Cowen and Company 32nd Annual Health Care Conference
Onyx will present at the Cowen and Company 32nd Annual Health Care Conference on Wednesday, March 7, 2012 at 9:20 a.m. Eastern Time (6:20 a.m. Pacific Time). 

24th Annual ROTH Conference
Onyx will present at the 24th Annual ROTH Conference on Monday, March 12, 2012 at 11:30 a.m. Eastern Time (8:30 a.m. Pacific Time). 

Barclays Capital Global Healthcare Conference
Onyx will present at the Barclays Capital Global Healthcare Conference on Tuesday, March 13, 2012 at 9:30 a.m. Eastern Time (6:30 a.m. Pacific Time). 

Interested parties may access a live webcast of the presentation on our website at:

http://www.onyx.com/investors/event-calendar

It is recommended that listeners log on 15 minutes early in order to register and download any necessary software.  For those unable to participate during the live webcast, a recorded replay of the presentation will be available within 24 hours of the completion of the presentation through the following dates:

  • 2012 Citi Global Healthcare Conference - March 12, 2012
  • Cowen and Company 32nd Annual Health Care Conference - March 21, 2012
  • 24th Annual ROTH Conference – March 26, 2012
  • Barclays Capital Global Healthcare Conference – March 27, 2012

 

About Onyx Pharmaceuticals, Inc.
Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer and other serious diseases.  The company is focused on developing novel medicines that target key molecular pathways. For more information about Onyx, visit the company's website at www.onyx.com.


'/>"/>
SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Avanir Pharmaceuticals to Participate in Citi 2012 Global Health Care Conference
2. Swedish Bactiguard to Enter Into an Exclusive Distribution Agreement With Cadila Pharmaceuticals
3. BioDelivery Sciences Receives Patent Allowance Triggering $15 Million Milestone Payment from Endo Pharmaceuticals
4. Questcor Pharmaceuticals to Present at the Leerink Swann Global Healthcare Conference on February 16, 2012
5. Plaintiff Sales Representatives and Novartis Pharmaceuticals Corporation Resolve Class Action Wage and Hour Claims
6. MAP Pharmaceuticals Appoints W. James OShea to Board of Directors
7. Inovio Pharmaceuticals to Present at Noble Financial 8th Annual Equity Conference
8. Reata Pharmaceuticals to Present at 30th Annual J.P. Morgan Healthcare Conference
9. Keryx Biopharmaceuticals to Present at JP Morgans 30th Annual Healthcare Conference
10. Inovio Pharmaceuticals Promotes Niranjan Sardesai to Chief Operating Officer
11. Amylin Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... NetworkNewsWire Editorial Coverage  ... Cancer remains one of ... health care systems, in terms of costs and resources. However, ... the development of innovative and efficient therapies that demonstrate higher ... types of cancer treatments, a growing number of patients receiving ...
(Date:3/23/2017)... , March 23, 2017  Agriculture technology company ... A financing and note conversion to commercialize its Cool ... is focused on developing products that are simultaneously profitable ... million in the last 18 months. This latest round ... Bridge Venture Partners. The company,s primary ...
(Date:3/23/2017)... ... March 23, 2017 , ... Advanced Polymer ... hire of Dr. Sigmund “Sig” Floyd as Vice President ? Global Business Development. ... development activities. , “Dr. Floyd’s career has spanned 30 years in the chemicals ...
(Date:3/22/2017)... ... March 22, 2017 , ... Researchers face a fundamental ... samples to full-size tissues, bones, even whole organs to implant in people to ... blood deep into the developing tissue. , Current bioengineering techniques, including 3-D ...
Breaking Biology Technology:
(Date:3/1/2017)...  Aware, Inc. (NASDAQ: AWRE), a leading supplier of ... Moberg has resigned, effective March 3, 2017, as ... and Treasurer of Aware citing a desire to retire.  ... of the Board of Directors of Aware. ... and co-President, General Counsel has been named Chief Executive ...
(Date:2/26/2017)... 25, 2017  Securus Technologies, a leading provider ... public safety, investigation, corrections and monitoring, announces the ... "Too often, too many offenders return ... jails are trying to tackle this ongoing problem ... and family members. While significant steps are underway, Securus ...
(Date:2/16/2017)... 16, 2017  Genos, a community for personal ... has received Laboratory Accreditation from the College of ... to laboratories that meet stringent requirements around quality, ... processes. "Genos is committed to maintaining ... We,re honored to be receiving CAP accreditation," said ...
Breaking Biology News(10 mins):